Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine

Journal of Medicinal Chemistry

Volumn 39, Issue 12, 1996, Pages 2427-2431

  Danel, Krzysztof ^a   Larsen, Erik ^a   Pedersen, Erik B ^a   Vestergaard, Bent F ^b   Nielsen, Claus ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 HYDROXYETHOXY)METHYL] 6 (PHENYLTHIO)THYMINE; 6 BENZYL 5 ETHYL 2',3' DIDEOXYURIDINE; 6 BENZYL 5 ETHYLURACIL; ANTIVIRUS AGENT; EMIVIRINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALKYLATION; ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1;

ALKYLATION; ANTIVIRAL AGENTS; CELL DIVISION; DRUG DESIGN; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; THYMINE; URACIL; VIRUS REPLICATION;

EID: 0029939554     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9600499     Document Type: Article

References (24)

1. Baba, M.; De Clercq, E.; Tanaka, H.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Umezu, K.; Walker, R. T.; Mori, S.; Ito, M.; Shigeta, S.; Miyasaka, T. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives. Mol. Pharmacol. 1991, 39, 805-810.
2. Balzarini, J.; Karlsson, A.; De Clercq, E. Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl-6-(phenylthio)-thymine derivatives. Mol. Pharmacol. 1993, 44, 694-701.
3. Baba, M.; Yuasa, S.; Niwa, T.; Yamamoto, M.; Yabuuchi, S.; Takashima, H.; Ubasawa, M.; Tanaka, H.; Miyasaka, T.; Walker, R. T.; Balzarini, J.; De Clercq, E.; Shigeta, S. Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding. Biochem. Pharmacol. 1993, 45, 2507-2512.
4. Miyasaka, T.; Tanaka, H.; De Clercq, E.; Baba, M.; Walker, R. T.; Ubasawa, M. Preparation of antiviral pyrimidine nucleosides. European Patent 449726 (October 2, 1991); Chem. Abstr. 1991, 116, 41986.
5. Miyasaka, T.; Tanaka, H.; De Clercq, E.; Baba, M.; Walker, R. T.; Ubasawa, M. Preparation of 6-substituted acyclopyrimidine nucleoside derivatives as virucides. European Patent Application 420763 (April 3, 1991); Chem. Abstr. 1991, 115, 158838.
6. Baba, M.; Tanaka, H.; Miyasaka, T.; Yuasa, S.; Ubasawa, M.; Walker, R. T.; De Clercq, E. HEPT derivatives: 6-Benzyl-ethoxymethyl-5-isopropyluracil (MKC-442). Nucleosides Nucleotides 1995, 14, 575-583.
7. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Inouye, N.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. J. Med. Chem. 1995, 38, 2860-2865.
8. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. J. Med. Chem. 1992, 35, 4713-4719.
9. Tanaka, H.; Baba, M.; Hayakawa, H.; Sakamaki, T.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; Balzarini, J.; De Clercq, E. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: Synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34, 349-357.
10. Pan, B. C.; Chen, Z.-H.; Piras, G.; Dutschman, G. E.; Rowe, E. C.; Cheng, Y. C.; Chu, S. H. Synthesis and anti-HIV-1 activities of 6-arylthio and 6-arylselenoacyclonucleosides. J. Heterocycl. Chem. 1994, 31, 177-185.
11. Danel, K.; Larsen, E.; Pedersen, E. B. An easy synthesis of 5,6-disubstituted acyclouridine derivatives. Synthesis 1995, 934-936.
12. Wittenburg, E. A new synthesis of nucleosides. Z. Chem. 1964, 4, 303-304.
13. Vorbrüggen, H.; Krolikiewiecz, K.; Bennua, B. Nucleoside synthesis with trimethylsilyl triflate and perchlorate as catalysts. Chem. Ber. 1981, 114, 1234-1255.
14. Hansen, P.; Pedersen, E. B. A simple synthetic route to silylated methyl 3-azido-2,3-dideoxy-α,β-D-erythro-pentofuranoside. Acta Chem. Scand. 1990, 44, 522-523.
15. Chaudhary, S. K.; Hernandez, O. 4-Dimethylaminopyridine: An efficient and selective catalyst for the silylation of alcohols. Tetrahedron Lett. 1979, 99-102.
16. Motawia, M. S.; Pedersen, E. B. A new route to 2′,3′-dideoxycytidine. Liebigs Ann. Chem. 1990, 599-602.
17. Okabe, M.; Sun, R.-C.; Tam, S. Y.-K.; Todaro, L. J.; Coffen, D. L. Synthesis of the dideoxynucleosides ddC and CNT from glutamic acid, ribonolactone, and pyrinidine bases. J. Org. Chem. 1988, 53, 4780-4786.
18. Baba, M.; Shigeta, S.; Yuasa, S.; Takashima, H.; Sekiya, K.; Ubasawa, M.; Tanaka, H.; Miyasaka, T.; Walker, R. T.; De Clercq, E. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrob. Agents Chemother. 1994, 38, 688-692.
19. Yuasa, S.; Sadakata, Y.; Takashima, H.; Sekiya, K.; Inoue, N.; Ubasawa, M.; Baba, M. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442. Mol. Pharmacol. 1993, 44, 895-900.
20. Chu, C. K.; Shinazi, R. F.; Arnold, B. H.; Cannon, D. L.; Doboszewski, B.; Bhadti, V. B.; Gu, Z. Comparative activity of 2′,3′-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Biochem. Pharmacol. 1988, 37, 3543-3548.
21. Popovic, M.; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Detection, isolation and continuous production of cytophathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224, 497-500.
22. Harada, S.; Koyanagi, Y.; Yamamoto, N. Infection of HTLV-III/ LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985, 229, 563-566.
23. Nielsen, C. M.; Bygbjerg, I. C.; Vestergaard, B. F. Detection of HIV antigens in eluates from whole blood collected on filter paper (Letter). Lancet 1987, No. 1, 566-567.
24. Mosmann, T. Rapid colorimetic assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.